Patent Assignment
Reel/Frame 073707/0488
Assignment of Assignor's Interest
Recorded: 2025-11-25
Pages: 12
Assignor
INOZYME PHARMA, INC.
Executed: 2025-07-01
Assignee
BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE, NOVATO, CALIFORNIA, 94949
Covered Properties
(51)
NPP1 Fusion Proteins
NPP1 Fusion Proteins
Application:
14/004,294 →
Publication:
US 2014/0154774
NPP1 Fusion Proteins
NPP1 Fusion Proteins
Application:
14/507,124 →
Publication:
US 2015/0024460
NPP1 Fusion Proteins
Application:
15/417,590 →
Publication:
US 2017/0145393
Methods of Treating Tissue Calcification
Methods of Treating Myointimal Proliferation
Methods of Improving Cardiovascular Function and Treating Cardiovascular Disease Using a Recombinant Ectonucleotide Pyrophosphatase Phosphodiesterase (NPP1)
NPP1 Fusion Proteins
Application:
17/105,245 →
Publication:
US 2021/0301268
Methods of Treating Tissue Calcification
Patent:
49,529 →
Application:
17/111,156 →
Treatment of Diseases Involving Deficiency of ENPP1 or ENPP3
Application:
17/178,127 →
Publication:
US 2021/0187067
Methods of Treating Myointimal Proliferation
Application:
17/747,379 →
Publication:
US 2022/0354933
NPP1 Fusion Proteins
Application:
17/819,065 →
Publication:
US 2023/0129977
Treatment of Diseases Involving Deficiency of ENPP1 or ENPP3
Application:
17/822,245 →
Publication:
US 2023/0031809
Compositions and Methods for Inhibiting Vascular Smooth Muscle Cell Proliferation
Application:
18/058,712 →
Publication:
US 2023/0330307
Compositions and Methods for Treating Peripheral Artery Disease
Application:
18/058,715 →
Publication:
US 2023/0372455
Soluble ENPP1 Proteins and Uses Thereof
Application:
18/063,263 →
Publication:
US 2023/0313158
Compositions and Methods for Treating Allograft Vasculopathy, Moyamoya Disease, Moyamoya Syndrome and Intimal Proliferation
Application:
18/148,888 →
Publication:
US 2024/0016951
Liver Specific Production of ENPP1 or ENPP3
Application:
18/297,228 →
Publication:
US 2024/0148907
Treatment of ENPP1 Deficiency and ABCC6 Deficiency
Application:
18/319,821 →
Publication:
US 2024/0181021
Lyophilized ENPP1 Polypeptide Formulations and Uses Thereof
Application:
18/612,571 →
Publication:
US 2025/0073319
Methods of Improving Cardiovascular Function and Treating Cardiovascular Disease Using a Recombinant Ectonucleotide Pyrophosphatase Phosphodiesterase (NPP1)
Application:
18/904,634 →
Publication:
US 2025/0019677
Treatment of ENPP1 Deficiency and ABCC6 Deficiency
Application:
18/904,807 →
Publication:
US 2025/0170223
NPP1 Fusion Proteins
Application:
19/183,431 →
Publication:
US 2026/0022356
NPP1 fusion protein
Application:
61/340,066 →
Method of Treating Tissue Calcification
Application:
62/094,943 →
Methods of Treating Tissue Calcification
Application:
62/249,781 →
Methods of Treating Myointimal Proliferation
Application:
62/350,936 →
Methods of Improving Cardiovascular Function and Treating Cardiovascular Disease Using a Recombinant Ectonucleotide Pyrophosphatase Phosphodiesterase (NPP1)
Application:
62/563,829 →
Treatment Diseases Involving Deficiency of ENPP1 or ENPP3
Application:
62/794,450 →
Treatment of Diseases Involving Deficiency of ENPP1 or ENPP3
Application:
62/821,692 →
Treatment of Diseases Involving Deficiency of ENPP1 or ENPP3
Application:
62/877,044 →
Compositions and Methods for Treating Peripheral Artery Disease
Application:
63/030,840 →
Compositions and Methods for Inhibiting Vascular Smooth Muscle Cell Proliferation
Application:
63/030,870 →
Soluble ENPP1 Proteins and Uses Thereof
Application:
63/036,833 →
Compositions and Methods for Treating Allograft Vasculopathy
Application:
63/047,793 →
Compositions and Methods for Treating Allograft Vasculopathy
Application:
63/047,848 →
Compositions and Methods for Preventing or Inhibiting Intimal Proliferation
Application:
63/047,865 →
Compositions and Methods for Treating Moyamoya Disease and Moyamoya Syndrome
Application:
63/047,877 →
Liver Specific Production of ENPP1 or ENPP3
Application:
63/089,515 →
Treatment of ENPP1 Deficiency
Application:
63/116,086 →
Treatment of diseases of pathological calcification
Application:
63/116,093 →
Treatment of ABCC6 Deficiency
Application:
63/116,106 →
Liver Specific Production of ENPP1 or ENPP3
Application:
63/165,650 →
Treatment of ENPP1 Deficiency
Application:
63/219,229 →
Treatment of ABCC6 Deficiency
Application:
63/237,351 →
Lyophilized ENPP1 Polypeptide Formulations and Uses Thereof
Application:
63/248,303 →
Liver Specific Production of ENPP1 or ENPP3
Application:
63/248,339 →
Treatment of ENPP1 Deficiency and ABCC6 Deficiency
Application:
63/327,215 →
Treatment of ENPP1 Deficiency and ABCC6 Deficiency in Children
Application:
63/578,137 →
Treatment of ENPP1 Deficiency and ABCC6 Deficiency in Infants
Application:
63/655,302 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 14, 2013
From: QUINN, ANTHONY; HARVEY, ALEX J.; XIA, ZHINAN
To: SYNAGEVA BIOPHARMA CORPORATION
Reel/Frame 031602/0203 →
Assignment of Assignor's Interest
Oct 14, 2014
From: QUINN, ANTHONY; HARVEY, ALEX J; XIA, ZHINAN
To: SYNAGEVA BIOPHARMA CORP.
Reel/Frame 033944/0883 →
Merger and Change of Name
Nov 15, 2016
From: SYNAGEVA BIOPHARMA CORP.; GALAXY MERGER SUB LLC
To: ALEXION PHARMA LLC
Reel/Frame 040329/0154 →
Assignment of Assignor's Interest
Nov 17, 2016
From: ALEXION PHARMA LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 040361/0470 →
Assignment of Assignor's Interest
Jul 14, 2017
From: QUIN, ANTHONY; HSIA, NELSON; KHAN, TAYEBA; ASKEW, KIM LYNNETTE
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 043009/0544 →
Corrective Assignment to Correct the Spelling of the Seventh Assignor's Name Previously Recorded on Reel 043009 Frame 0544. Assignor(S) Hereby Confirms the Assignment.
Aug 1, 2017
From: QUIN, ANTHONY; HSIA, NELSON; KHAN, TAYEBA; ASKEW, KIM LYNETTE
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 043400/0614 →
Assignment of Assignor's Interest
Dec 12, 2018
From: YAN, YAN; SHAH, ANUMEHA; SAIGAL, ASHMITA; GRIFFIN, HERMAN
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 047753/0925 →
Assignment of Assignor's Interest
Dec 12, 2018
From: RUTSCH, FRANK; NITSCHKE, YVONNE
To: WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Reel/Frame 047753/0894 →
Merger and Change of Name
Jan 14, 2020
From: SYNAGEVA BIOPHARMA CORP.; GALAXY MERGER SUB LLC
To: ALEXION PHARMA LLC
Reel/Frame 051507/0790 →
Assignment of Assignor's Interest
Jan 14, 2020
From: ALEXION PHARMA LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 051507/0860 →
Assignment of Assignor's Interest
Jan 14, 2020
From: QUINN, ANTHONY; HARVEY, ALEX J.; XIA, ZHINAN
To: SYNAGEVA BIOPHARMA CORPORATION
Reel/Frame 051507/0716 →
Assignment of Assignor's Interest
Mar 19, 2020
From: KHAN, TAYEBA; MAROZSAN, ANDRE; ASKEW, KIM
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 052167/0646 →
Assignment of Assignor's Interest
Nov 9, 2020
From: ALEXION PHARMACEUTICALS, INC.
To: INOZYME PHARMA, INC.
Reel/Frame 054315/0445 →
Assignment of Assignor's Interest
Nov 9, 2020
From: ALEXION PHARMACEUTICALS, INC.
To: INOZYME PHARMA, INC.
Reel/Frame 054315/0468 →
Assignment of Assignor's Interest
Nov 23, 2020
From: ALEXION PHARMACEUTICALS, INC.
To: INOZYME PHARMA, INC.
Reel/Frame 054449/0251 →
Assignment of Assignor's Interest
May 4, 2021
From: BRADDOCK, DEMETRIOS
To: YALE UNIVERSITY
Reel/Frame 056128/0586 →
Corrective Assignment to Correct the Execution Date of the Assignment Previously Recorded at Reel: 040361 Frame: 0470. Assignor(S) Hereby Confirms the Assignment.
Aug 9, 2021
From: ALEXION PHARMA LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 057127/0791 →
Assignment of Assignor's Interest
Jul 28, 2022
From: RUTSCH, FRANK; NITSCHKE, YVONNE
To: WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Reel/Frame 060650/0826 →
Assignment of Assignor's Interest
Jul 28, 2022
From: ALEXION PHARMACEUTICALS, INC.
To: INOZYME PHARMA, INC.
Reel/Frame 060650/0836 →
Assignment of Assignor's Interest
Jul 28, 2022
From: YAN, YAN; SHAH, ANUMEHA; SAIGAL, ASHMITA; GRIFFIN, HERMAN
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 060650/0966 →
Assignment of Assignor's Interest
Sep 9, 2022
From: JUNGLES, STEVEN
To: INOZYME PHARMA, INC.
Reel/Frame 061046/0273 →
Assignment of Assignor's Interest
Jan 27, 2023
From: RUTSCH, FRANK; NITSCHKE, YVONNE
To: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
Reel/Frame 062516/0725 →
Assignment of Assignor's Interest
Jan 27, 2023
From: RUTSCH, FRANK; NITSCHKE, YVONNE
To: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
Reel/Frame 062516/0577 →
Assignment of Assignor's Interest
Jan 27, 2023
From: RUTSCH, FRANK; NITSCHKE, YVONNE
To: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
Reel/Frame 062516/0813 →
Assignment of Assignor's Interest
Feb 1, 2023
From: THOMPSON, DAVID
To: INOZYME PHARMA, INC.
Reel/Frame 062564/0994 →